Conventional cytogenetics analysis identifies patients with translocation of MYC and BCL2 and/or BCL6 as a subgroup of aggressive B-cell lymphoma with poor prognosis and phenotypic proximity to Burkitt lymphoma [2]. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.